Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin pharmacokinetics in critically ill ICU patients receiving VTE prophylaxis
NL-OMON38854Active, not recruiting
- Sponsor
- Meander Medical Center
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of nadroparin in venous thromboembolism (VTE), sponsored by Meander Medical Center. Primary endpoint: Quantitative description of nadroparin pharmacokinetics in critically ill patients. Started Dec 2014; status: active, not recruiting.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON38854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38854.